Melissa Adams: Daily

With a fresh $6.5M, Marquee is tackling sports' 'data rich, decision poor' crisis, turning siloed information into a strategic advantage for top clubs.

The acquisition signals a major shift from AI-powered advice to autonomous action, creating a new global powerhouse aiming to redefine the customer experience.

The specialty underwriter reports impressive Q2 earnings, driven by a strategic pivot to insurance services while navigating a softening reinsurance market.

New data shows 18M+ Americans have Long Covid. With US insurers denying a promising but unproven treatment, many are spending thousands to go abroad.

As RenovoRx preps its Q2 update, it's proving its mettle on two fronts: impressive sales of its RenovoCath device and a critical milestone in its pancreatic cancer trial.

In a major move for defense tech, cybersecurity veteran Dave DeWalt joins the board of AI unicorn Air, signaling a high-stakes bet on solving the military's deep logistical gaps.

A new volunteer program isn't just about a fresh coat of paint. It's a strategic fusion of product innovation, color psychology, and community partnership.

T-REX launches RAMZ, a 2x inverse ETF targeting the red-hot memory chip sector. Is it a smart hedge or a high-risk gamble on the end of the AI rally?

As attackers weaponize AI, Intel 471's new Agent471 and MCP471 tools aim to shift cyber defense from reaction to preemption. Is this the future?

Power Solutions International appoints Richard Hu, a global industrial leader, as its new CEO. Is his deep operational expertise the key to unlocking the lucrative data center market?

As Telos preps its Q2 report, investors weigh strong growth and new contracts against leadership changes. Can the cybersecurity firm meet high expectations?

Beyond impressive Q2 numbers, Bank of Marin’s comeback reveals a masterclass in strategic de-risking and disciplined execution that offers lessons for the sector.

As Melamoon 2026 heads to Toronto, we look past the $200,000 prize to see how this pitch tour is tackling systemic barriers for Black founders.

Radiopharm Theranostics secures crucial funding for its promising oncology pipeline, but a sharp stock drop reveals deep investor concerns about dilution.

Freedom Mobile now offers 5G+ on all plans at no extra cost, challenging the Big Three. Is this the move that finally democratizes high-speed mobile for Canadians?

Havas reports solid H1 growth, leaning on its AI strategy and a booming North American market to offset significant headwinds in Europe and Asia.

A Utah startup and 29 Caribbean ports are tackling a $20B problem. GenFlat's foldable containers promise efficiency, but can they overcome industry inertia?

UMeWorld's new venture in China aims to crack the SAF code with single-cell oil, a scalable feedstock that could finally break the industry's reliance on waste oils.

Life Science Connect's partnership with PMWC moves the 'Davos of Precision Medicine' beyond an annual event, creating a continuous digital and physical ecosystem.

A Virginia tech firm patented a 'living trust profile' you control. Will this kill data fatigue and protect firms from breaches, or create new digital divides?